Prothena Corp PLC (PRTA)
13.56
-0.18 -1.31%
NASDAQ
Jan 20, 16:59
USD
Prothena Sell Recommendations
View 4,000+ financial data types
Browse...
View Full Chart
Sell Recommendations Chart
Historical Sell Recommendations Data
View and export this data going back to 2016.
Start your Free Trial
Export Data
Date Range:
Data for this Date Range | |
---|---|
Jan. 10, 2021 | Upgrade |
Dec. 23, 2020 | Upgrade |
Dec. 15, 2020 | Upgrade |
Dec. 10, 2020 | Upgrade |
Dec. 9, 2020 | Upgrade |
Dec. 7, 2020 | Upgrade |
Nov. 25, 2020 | Upgrade |
Nov. 19, 2020 | Upgrade |
Nov. 11, 2020 | Upgrade |
Nov. 6, 2020 | Upgrade |
Nov. 5, 2020 | Upgrade |
Nov. 4, 2020 | Upgrade |
Oct. 21, 2020 | Upgrade |
Oct. 20, 2020 | Upgrade |
Oct. 18, 2020 | Upgrade |
Oct. 6, 2020 | Upgrade |
Sept. 16, 2020 | Upgrade |
Sept. 15, 2020 | Upgrade |
Sept. 13, 2020 | Upgrade |
Sept. 11, 2020 | Upgrade |
Aug. 20, 2020 | Upgrade |
Aug. 10, 2020 | Upgrade |
Aug. 9, 2020 | Upgrade |
Aug. 7, 2020 | Upgrade |
Aug. 6, 2020 | Upgrade |
July 24, 2020 | Upgrade |
July 14, 2020 | Upgrade |
July 9, 2020 | Upgrade |
July 8, 2020 | Upgrade |
July 7, 2020 | Upgrade |
July 3, 2020 | Upgrade |
July 1, 2020 | Upgrade |
June 17, 2020 | Upgrade |
June 5, 2020 | Upgrade |
May 13, 2020 | Upgrade |
May 11, 2020 | Upgrade |
May 10, 2020 | Upgrade |
May 7, 2020 | Upgrade |
May 4, 2020 | Upgrade |
April 23, 2020 | Upgrade |
April 22, 2020 | Upgrade |
April 3, 2020 | Upgrade |
March 31, 2020 | Upgrade |
March 30, 2020 | Upgrade |
March 23, 2020 | Upgrade |
March 18, 2020 | Upgrade |
March 2, 2020 | Upgrade |
Feb. 18, 2020 | Upgrade |
Feb. 14, 2020 | Upgrade |
Feb. 13, 2020 | Upgrade |
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
View Sell Recommendations for PRTA
Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
Start your free 7-Day Trial.
Start My Free Trial
No credit card required.
Already a subscriber? Sign in.
Advertisement
Sell Recommendations Benchmarks
Alkermes PLC | Upgrade |
Amarin Corp PLC | Upgrade |
Jazz Pharmaceuticals PLC | Upgrade |
Sell Recommendations Range, Past 5 Years
Minimum | Upgrade | Jan 20 2016 |
Maximum | Upgrade | Jan 20 2016 |
Average | Upgrade |
News
Sector Update: Consumer Staples, Discretionary Stocks Closing Gap Slightly Just Ahead of Tuesday's Close
MT Newswires 01/12 15:54 ET
MT Newswires 01/12 15:54 ET
--Analyst Actions: Oppenheimer Adjusts Prothena's Price Target to $25 From $20, Maintains Outperform Rating
MT Newswires 12/10 11:09 ET
MT Newswires 12/10 11:09 ET
Prothena Reports Positive Data From Phase 1 Study of PRX004 to Treat ATTR Amyloidosis; Shares Surge 25% Pre-Bell
MT Newswires 12/09 08:56 ET
MT Newswires 12/09 08:56 ET
Prothena's immunotherapy show slowing neuropathy progression in long-term amyloidosis study
SA Breaking News 12/09 08:38 ET
SA Breaking News 12/09 08:38 ET
Analyst Actions: HC Wainwright Starts Prothena at Buy With $22 Price Target
MT Newswires 12/07 08:00 ET
MT Newswires 12/07 08:00 ET
Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire 12/04 16:05 ET
Globe Newswire 12/04 16:05 ET
Here's Why We're Not Too Worried About Prothena's (NASDAQ:PRTA) Cash Burn Situation
Yahoo 11/16 02:56 ET
Yahoo 11/16 02:56 ET
--Analyst Actions: Oppenheimer Adjusts Prothena PT to $20 From $18, Maintains Outperform Rating
MT Newswires 11/05 12:23 ET
MT Newswires 11/05 12:23 ET
-- Earnings Flash (PRTA) PROTHENA CORPORATION Reports Q3 Revenue $157,000, vs. Street Est of $0.193M
MT Newswires 11/04 16:41 ET
MT Newswires 11/04 16:41 ET
Prothena Reports Third Quarter 2020 Financial Results and Provides R&D Update
Globe Newswire 11/04 16:05 ET
Globe Newswire 11/04 16:05 ET
Prothena Announces Presentations on Two Programs from its Alzheimer’s Disease Portfolio at CTAD 2020
Globe Newswire 11/04 08:30 ET
Globe Newswire 11/04 08:30 ET
Advertisement